Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study (2022) Salzmann M, Wald A, Stege H, Loquai C, Zimmer L, Hayani K, Heinzerling L, et al. Conference contribution Which patients should receive adjuvant treatment - an analysis of stage IIA-IIIA patients of the CMMR (2022) Leiter-Stoppke U, Keim U, Amaral T, Forschner A, Berking C, Gesierich A, Gutzmer R, et al. Conference contribution The quality of national skin cancer screening from the perspective of general practitioners: A questionnaire-based comparison between Saxony and Bavaria (SaBaScreen) (2022) Strasser C, Reinhardt L, Steeb T, Wessely A, Schelling J, Petzold A, Heppt M, et al. Conference contribution A novel splice variant of Argonaut 2 affects microRNA target genes and cell viability of melanoma cells (2022) Linck-Paulus L, Horn A, Matthies AO, Fischer S, Meister G, Sticht H, Kappelmann-Fenzl M, Boßerhoff AK Conference contribution SOX10-based drug repurposing identifies novel therapeutic targets in uveal melanoma (2022) Wessely A, Kammerbauer C, Lischer C, Weich A, Vera J, Berking C, Heppt M Conference contribution In vitro assessment of checkpoint-induced cytokine levels as new tool in the therapeutic decision-making process after checkpoint-induced cytokine release syndrome in metastatic melanoma (2022) Kramer R, Bender-Säbelkampf S, Berking C, Heppt M, Erdmann M, Bosch-Voskens C Conference contribution Molecular analysis of tumor dormancy of the malignant 3D printed model of melanoma (2022) Schmidt S, Fischer S, Schmid R, Arkudas A, Kengel-Bach-Weigand A, Kappelmann-Fenzl M, Boßerhoff AK Conference contribution Detection and quantification of cellular senescence in human melanocytes and melanoma cell lines (2022) Zimmermann T, Pommer M, Kluge V, Chiheb C, Mühlich S, Boßerhoff AK Conference contribution A single-center, retrospective Analysis for the Detection of Distant Metastases in Patients with regionally metastatic Melanoma in the Era of effective adjuvant Therapies (2022) Toussaint F, Kramer RA, Bender-Säbelkampf S, Hornung-Eichler A, Karimi B, Heppt M, Bosch-Voskens C, et al. Conference contribution Primary cutaneous manifestation of systemically aggressive diffuse large B-cell lymphoma (2022) Bender-Säbelkampf S, Spriewald B, Berking C, Erdmann M, Wagner N Conference contribution